GlassScriptPhysician profile
Michelle S Peters
NPI 1306255138
$3,450.96
in general payments reported to CMS, 2019-2025
24 companies · $25.54 in 2025
The $25.54 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $724 · 2022: $2,041 · 2023: $622 · 2024: $39.37 · 2025: $25.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $716.23 | 2021-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.65 | 2021-2023 | Ofev, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $434.63 | 2021-2023 | Bevespi Aerosphere, Fasenra, Breztri |
| Actelion Pharmaceuticals US, INC. | $421.74 | 2021-2023 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $310.77 | 2021-2023 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $168.47 | 2021-2023 | |
| Baxter Healthcare | $155.57 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $151.29 | 2022-2023 | Smartvest |
| Amgen INC. | $136.51 | 2021-2023 | Tezspire |
| Abbvie INC. | $123.90 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.99 | 2021-2024 | Vpriv |
| Inogen, INC. | $43.17 | 2022 | |
| Covis Pharma Gmbh | $40.08 | 2021 | |
| Intuitive Surgical, INC. | $29.87 | 2022 | |
| Abiomed | $25.54 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $24.07 | 2022 | |
| Genentech USA, INC. | $19.48 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.23 | 2021 | |
| United Therapeutics Corporation | $17.57 | 2021 | |
| Philips North America LLC | $16.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.59 | 2022 | |
| Advanced Respiratory, INC | $16.17 | 2021 | |
| Merck Sharp & Dohme LLC | $16.09 | 2021 | |
| Chiesi USA, INC. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.